TTR and melanoma: To address whether POSTN expression leads to presence of intratumoral TTR macrophages and resistance formation to targeted therapy in vivo, we sought to establish an immunocompetent melanoma mouse model system that is normally responsive to inhibition of the MAPK kinase pathway.